» Articles » PMID: 21896243

Plasma Appearance and Disappearance of an Oral Dose of 25-hydroxyvitamin D2 in Healthy Adults

Overview
Journal Br J Nutr
Date 2011 Sep 8
PMID 21896243
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

25-Hydroxyvitamin D (25(OH)D) half-life is a potential biomarker for investigating vitamin D metabolism and requirements. We performed a pilot study to assess the approach and practical feasibility of measuring 25(OH)D half-life after an oral dose. A total of twelve healthy Gambian men aged 18-23 years were divided into two groups to investigate the rate and timing of (1) absorption and (2) plasma disappearance after an 80 nmol oral dose of 25(OH)D2. Fasting blood samples were collected at baseline and, in the first group, every 2 h post-dose for 12 h, at 24 h, 48 h and on day 15. In the second group, fasting blood samples were collected on days 3, 4, 5, 6, 9, 12, 15, 18 and 21. Urine was collected for 2 h after the first morning void at baseline and on day 15. 25(OH)D2 plasma concentration was measured by ultra-performance liquid chromatography-tandem MS/MS and corrected for baseline. Biomarkers of vitamin D, Ca and P metabolism were measured at baseline and on day 15. The peak plasma concentration of 25(OH)D2 was 9·6 (sd 0·9) nmol/l at 4·4 (sd 1·8) h. The terminal slope of 25(OH)D2 disappearance was identified to commence from day 6. The terminal half-life of plasma 25(OH)D2 was 13·4 (sd 2·7) d. There were no significant differences in plasma 25(OH)D3, total 1,25(OH)2D, parathyroid hormone, P, Ca and ionised Ca and urinary Ca and P between baseline and day 15 and between the two groups. The present study provides data on the plasma response to oral 25(OH)D2 that will underpin and contribute to the further development of studies to investigate 25(OH)D half-life.

Citing Articles

Interplay between Vitamin D and Adipose Tissue: Implications for Adipogenesis and Adipose Tissue Function.

Lu S, Cao Z Nutrients. 2023; 15(22).

PMID: 38004226 PMC: 10675652. DOI: 10.3390/nu15224832.


Vitamin D and Obesity/Adiposity-A Brief Overview of Recent Studies.

Bennour I, Haroun N, Sicard F, Mounien L, Landrier J Nutrients. 2022; 14(10).

PMID: 35631190 PMC: 9143180. DOI: 10.3390/nu14102049.


Vitamin D kinetics in nonpregnant and pregnant women after a single oral dose of trideuterated vitamin D.

Best C, Sherwood R, Novotny J, Zhang S, Pressman E, OBrien K J Steroid Biochem Mol Biol. 2021; 216:106034.

PMID: 34843870 PMC: 8749867. DOI: 10.1016/j.jsbmb.2021.106034.


The role of vitamin D and vitamin D deficiency in orthopaedics and traumatology-a narrative overview of the literature.

Maier G, Weissenberger M, Rudert M, Roth K, Horas K Ann Transl Med. 2021; 9(11):942.

PMID: 34350257 PMC: 8263860. DOI: 10.21037/atm-21-779.


Analytical Bias in the Measurement of Plasma 25-Hydroxyvitamin D Concentrations in Infants.

Rueter K, Black L, Jones A, Bulsara M, Clarke M, Gamez C Int J Environ Res Public Health. 2020; 17(2).

PMID: 31936279 PMC: 7014414. DOI: 10.3390/ijerph17020412.


References
1.
Nilsson S, Ostberg L, Peterson P . Binding of vitamin D to its human carrier plasma protein. Biochem Biophys Res Commun. 1972; 46(3):1380-7. DOI: 10.1016/s0006-291x(72)80128-1. View

2.
Rapuri P, Gallagher J, Haynatzki G . Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter. Calcif Tissue Int. 2003; 74(2):150-6. DOI: 10.1007/s00223-003-0083-8. View

3.
Haddad Jr J, Rojanasathit S . Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab. 1976; 42(2):284-90. DOI: 10.1210/jcem-42-2-284. View

4.
Davies M, Mawer E, Krawitt E . Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease. Gut. 1980; 21(4):287-92. PMC: 1419609. DOI: 10.1136/gut.21.4.287. View

5.
Sitrin M, Pollack K, Bolt M, Rosenberg I . Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat. Am J Physiol. 1982; 242(4):G326-32. DOI: 10.1152/ajpgi.1982.242.4.G326. View